Explore the Global Human Immunodeficiency Virus Type 1 (HIV 1) Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Human Immunodeficiency Virus Type 1 (HIV 1) Market

Key Insight

FMI opines the human immunodeficiency virus type 1 (hiv 1) market was valued at USD 39.10 billion in 2025. Sales are expected to reach USD 41.45 billion in 2026 and USD 74.22 billion by 2036. Integrase Inhibitors is poised to lead by Drug Class with 35.7% share in 2026.

April 10, 2026

Anurag Sharma

280 Pages

Cite this Report

Human Immunodeficiency Virus Type 1 (HIV 1) Market

https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Boehringer Ingelheim
Bristol-Myers Squibb

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Human Immunodeficiency Virus Type 1 (HIV 1) Market

Key Players

Similar Industry Reports